Nanobiotix Sa - Adr (NBTX) Technical Analysis
$30.27
Market is closed - opens 7 PM, 08 Apr 2026
Insights
- Nanobiotix Sa - Adr is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Nanobiotix Sa - Adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Nanobiotix Sa - Adr stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Nanobiotix Sa - Adr stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 48.62 | Neutral |
Stochastic | 27.88, 46.47 | Neutral |
Ultimate Oscillator | 49.5 | Neutral |
Stochastic Relative Strength Index | 36.41, 52.79 | Neutral |
Moving Average Convergence Divergence | 0.55, 0.84 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.06 | Sell |
20 | 31.85 | Buy |
50 | 28.44 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.38 | Buy |
20 | 31.19 | Buy |
50 | 29.04 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.17 | Neutral |
20 | 32.2 | Sell |
50 | 30.89 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.32 | Sell |
20 | 32.1 | Sell |
50 | 32.42 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.27 | Buy |
20 | 31.19 | Sell |
50 | 33.5 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 35.25 |
Resistance L2 | 34.06 |
Resistance L1 | 33.41 |
Pivot Point | 32.22 |
Support L1 | 31.57 |
Support L2 | 30.38 |
Support L3 | 29.73 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.